Amneal Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Amneal Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2023.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $43.3M, a 22.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $43.3M -$12.8M -22.9% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $56.1M -$4.25M -7.04% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $60.4M +$1.63M +2.78% Dec 31, 2021 10-K 2023-03-03
Q4 2020 $58.7M -$11.1M -15.9% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $69.9M -$15.1M -17.8% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $71.4M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $76.9M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $80.8M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $85M Jan 1, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.